Tiny study sheds light on rare male breast cancer
NCT ID NCT06133647
First seen Apr 23, 2026 · Last updated May 12, 2026 · Updated 4 times
Summary
This study reviewed the medical records of 8 men treated for breast cancer at Methodist Health System. The goal was to understand their backgrounds, how the cancer responded to treatment, and long-term outcomes like survival and recurrence. Because it only looked back at past data and did not test a new treatment, it helps gather knowledge about a rare condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DUCTAL CARCINOMA IN SITU are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Research Institute at Methodist Health System
Dallas, Texas, 75203, United States
Conditions
Explore the condition pages connected to this study.